Clinical trials: sponsored by Peking University
Ablation, Breast Cancer
A Cohort Study of Combined Cryoablation and Thermal Ablation for Non-surgical Treatment of Breast Cancer Patients
Although surgical resection is the gold standard for early breast cancer treatment, some patients cannot tolerate surgery due to medical conditions or refuse surgical treatment for cosmetic reasons.
- Trial name
- NCT07238894
- Testing
- Combined Cryoablation and Thermal Ablation system
- Where
- China
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- Peking University People's Hospital
Hormone Receptor-Positive Breast Cancer, High-risk Breast Cancer
ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer
This is a Phase II, multicenter, randomized clinical trial evaluating a ctDNA-guided approach to de-escalate adjuvant chemotherapy in patients with hormone receptor (HR)-positive, HER2-negative early-stage breast cancer.
- Conditions
- Hormone Receptor-Positive Breast Cancer, High-risk Breast Cancer, Early-Stage Breast Cancer, HER2-negative Breast Cancer
- Trial name
- DNADalHR (NCT06970912)
- Testing
- Dalpiciclib + Aromatase Inhibitor with ctDNA-Guided Therapy, Taxane-Based Neoadjuvant Chemotherapy
- Where
- China
- Volunteers
- 393 people
- Sponsor
- Peking University People's Hospital
Hormone Receptor-Positive Breast Cancer, High-risk Breast Cancer
CDK4/6 Inhibitors Combined With Endocrine Therapy for Neoadjuvant Treatment
Exploring the dynamics of ctDNA following neoadjuvant therapy with CDK4/6 inhibitors combined with endocrine treatment, and its potential to guide de-escalation of adjuvant chemotherapy
- Conditions
- Hormone Receptor-Positive Breast Cancer, High-risk Breast Cancer, Early-Stage Breast Cancer, HER2-negative Breast Cancer
- Trial name
- DNACDKHR (NCT07366112)
- Testing
- CDK4/6 inhibitor with endocrine therapy
- Where
- China
- Volunteers
- 158 people
- Sponsor
- Peking University People's Hospital
HER2 + Breast Cancer, Advanced Breast Cancer
Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer
Given that pyrotinib has been proven to exert significant efficacy against HER2-positive advanced breast cancer in multiple Phase III studies, and the novel ADC drug disitamab vedotin has demonstrated potent anti-tumor activity…
- Trial name
- NCT07600164
- Testing
- Pyrotinib, Trastuzumab Rezetecan
- Where
- China
- Volunteers
- 500 people
- Sponsor
- Peking University People's Hospital
Type 2 Diabetes Mellitus (T2DM)
hUC-MSC-Exosomes for T2DM - Safety & Efficacy
The goal of this clinical trial is to Evaluate the Safety and Preliminary Efficacy of Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Adult Type 2 Diabetes Mellitus.
- Trial name
- HOPE-T2DM (NCT07693036)
- Testing
- exosomes treatment group, control group
- Where
- China
- Volunteers
- 66 people
- Sponsor
- Peking University First Hospital
Idiopathic Inflammatory Myopathies (IIMs)
Clinical Characteristics and Mechanism Research of Deucravacitinib in the Idiopathic Inflammatory Myopathies
This study aims to explore the clinical characteristics and mechanism of Deucravacitinib in the treatment of idiopathic inflammatory myopathies.Detailed Description: The investigators designed a single center, open-label…
- Trial name
- NCT07564271
- Testing
- Deucravacitinib 6mg po qd
- Where
- China
- Sponsor
- Peking University People's Hospital
Nausea and Vomiting Induced by Antibody-drug Conjugates (ADCs)
Fosrolapitant and Palonosetron for the Prevention of Antibody-drug Conjugate-induced Nausea and Vomiting
This study is aimed to evaluate the efficacy and safety of Fosrolapitant and Palonosetron for Antibody-drug conjugate-induced nausea and vomiting
- Trial name
- NCT07692451
- Testing
- Fosrolapitant and Palonosetron for injection
- Volunteers
- 124 people
- Sponsor
- Peking University Cancer Hospital & Institute
Primiparous Women
Combined Misoprostol and Cervical Balloon vs Misoprostol Alone for Induction on the First Day in Primiparas
Misoprostol (a prostaglandin E1 analog) is commonly used for cervical ripening and labor induction via vaginal administration. The cervical balloon is another commonly used method that provides mechanical cervical dilation.
- Trial name
- NCT07690007
- Testing
- Misoprostol, Misoprostol plus Cervical Balloon
- Volunteers
- 220 people
- Sponsor
- Peking University First Hospital
Polycystic Ovary Syndrome (PCOS), Obesity
Effects of GLP-1RAs on Fertility Outcomes in Obese Women With PCOS
The goal of this clinical trial is to examine whether GLP1-RA and healthy lifestyle education in women with PCOS and obesity prior to fertility treatment improves live birth rate and other reproductive, maternal and perinatal…
- Conditions
- Polycystic Ovary Syndrome (PCOS), Obesity, Infertility, Female
- Trial name
- NCT07687667
- Testing
- GLP-1 receptor agonist, Metformin
- Where
- China
- Volunteers
- 406 people
- Sponsor
- Peking University Third Hospital
Cirrhosis With Spontaneous Bacterial Peritonitis
Clinical Study on the Effectiveness of Antibiotics Combined With Bifidobacterium Quadruple Live Tablets in Treating Cirrhosis With Spontaneous Bacterial Peritonitis and Preventing Recurrence
This is a prospective, randomized, double-blind, placebo-controlled multicenter clinical study targeting cirrhosis patients with Spontaneous Bacterial Peritonitis(SBP), aiming to evaluate whether adding Bifidobacterium quadruple…
- Trial name
- NCT07686861
- Testing
- Bifidobacterium quadruple live tablets
- Where
- 30 sites in China
- Volunteers
- 360 people
- Sponsor
- Peking University First Hospital
Facial Aging, Melomental Folds
Botulinum Toxin Type A Injection Sites for Oral Commissure Ptosis
This multicenter, prospective, randomized parallel-controlled, assessor-blinded clinical trial aims to address the core clinical pain point of lack of high-level evidence and non-standardized operation in injection site selection…
- Conditions
- Facial Aging, Melomental Folds, Oral Commissure Ptosis
- Trial name
- NCT07646886
- Testing
- OnabotulinumtoxinA (Upper Depressor Anguli Oris Injection), OnabotulinumtoxinA (Lower Depressor Anguli Oris Injection)
- Volunteers
- 266 people
- Sponsor
- Peking University
Old Age, Knee Replacement Surgery
Mini-dose Dexmedetomidine-Esketamine Infusion and Perioperative Sleep Quality
Sleep disturbances are prevalent in older patients with osteoarthrosis or fracture who are scheduled for knee or hip replacement surgery.
- Conditions
- Old Age, Knee Replacement Surgery, Hip Replacement Surgery, Dexmedetomidine
- Trial name
- NCT05950646
- Testing
- Dexmedetomidine, Esketamine, Normal saline
- Where
- 2 sites in China
- Volunteers
- 154 people
- Sponsor
- Peking University First Hospital
Severe Aplastic Anemia, Aplastic Anaemia
A Novel Conditioning Regimen for Haplo-HSCT in Older Patients With SAA
The goal of this prospective, multicenter, single arm observational study is to evaluate the efficacy and safety of the BFCA regimen in ≥ 40 years old SAA patients undergoing haplo-HSCT.
- Conditions
- Severe Aplastic Anemia, Aplastic Anaemia, Hematopoietic Cell Transplant
- Trial name
- NCT07586735
- Testing
- BFCA conditiong regimen
- Where
- China
- Volunteers
- 64 people
- Sponsor
- Peking University People's Hospital
Major Depressive Disorder (MDD), Neuroimaging
Efficacy of Bright Light Therapy on Cognitive Impairment in Major Depressive Disorder and Its Neuroimaging Mechanisms: Protocol for a Randomised Controlled Trial
This study aims to validate the therapeutic efficacy and safety of bright light therapy (BLT) in ameliorating cognitive impairment (CI) in major depressive disorder (MDD), characterize the functional and structural features of…
- Conditions
- Major Depressive Disorder (MDD), Neuroimaging, Bright Light Treatment, Cognitive Impairment
- Trial name
- NCT07508215
- Testing
- BLT, DRL
- Where
- 2 sites in China
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- Peking University Sixth Hospital
Type2diabetes, Pregnancy Related
Real Time Continuous Glucose Monitoring System in T2DM With Pregnacy
The prevalence of type 2 diabetes mellitus (T2DM) in women of childbearing age is increasing rapidly, and low glucose compliance leads to an increased risk of adverse pregnancy outcomes for mothers and infants during pregnancy in…
- Conditions
- Type2diabetes, Pregnancy Related, Continuous Glucose Monitoring, Time in Range
- Trial name
- NCT05947916
- Testing
- Real-time Continuous Glucose Monitoring System
- Where
- China
- Volunteers
- 240 people
- Sponsor
- Peking University Third Hospital
Older Patients, Postoperative Care
Sedation With Dexmedetomidine-esketamine Combination and Delirium in ICU Patients
Patients in the intensive care unit (ICU) often develop anxiety and agitation, sleep disturbances, and delirium. Delirium occurrence is associated with worse early and long-term outcomes.
- Conditions
- Older Patients, Postoperative Care, Intensive Care Unit, Dexmedetomidine
- Trial name
- NCT07151716
- Testing
- Dexmedetomidine, Dexmedetomidine-esketamine combination
- Where
- China
- Volunteers
- 100 people
- Sponsor
- Peking University First Hospital
Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma
Retlirafusp Alfa Injection Plus Chemotherapy Versus Investigator's Choice of Anti-PD-1 Antibody Plus Chemotherapy as First-line Treatment for Advanced Gastric Cancer With Liver Metastases
This study is a randomized, controlled, open-label phase III clinical trial, aims to compare the efficacy and safety of Retlirafusp alfa injection plus CAPOX versus the investigator's choice of anti-PD-1 antibody plus CAPOX as…
- Trial name
- NCT07677293
- Testing
- Retlirafusp alfa Injection, Capecitabine, Oxaliplatin
- Volunteers
- 332 people
- Sponsor
- Peking University
Antiphospholipid (aPL)-Positive, Thrombocytopaenia
Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia
The goal of this clinical trial is to evaluate the efficacy and safety of sirolimus in patients with anti-phospholipid antibody-associated thrombocytopenia.
- Trial name
- SMART (NCT06722586)
- Testing
- Sirolimus
- Where
- 10 sites in China
- Volunteers
- 84 people
- Sponsor
- Peking University First Hospital
Partial Rotator Cuff Tears (PRCTs)
High-frequency Short-course Extracorporeal Shock Wave Therapy for Partial Rotator Cuff Tears: Study Protocol for a Multicenter, Randomized, Controlled Trial
This is a multicenter, randomized controlled clinical study exploring three different extracorporeal shock wave therapy (ESWT) regimens for patients with partial rotator cuff tears, a common cause of chronic shoulder pain and…
- Trial name
- NCT07673055
- Testing
- Arm 1 Intervention Name: High-frequency short-course extracorporeal shock wave therapy Arm 2 Intervention Name: High-frequency intensive extracorporeal shock wave therapy Arm 3 Intervention Name: Conv
- Volunteers
- 300 people, healthy volunteers welcome
- Sponsor
- Peking University Third Hospital
Parkinson's Disease, Multiple System Atrophy
Individualized Transcranial Magnetic Stimulation in Parkinsonian Disorders
This clinical trial aims to evaluate whether individualized targeted repetitive transcranial magnetic stimulation (rTMS) can improve motor and non-motor symptoms in patients with parkinsonian disorders.
- Conditions
- Parkinson's Disease, Multiple System Atrophy, Progressive Supranuclear Palsy
- Trial name
- NCT07570212
- Testing
- TMS
- Where
- China
- Volunteers
- 50 people
- Sponsor
- Peking University First Hospital
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.